Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,800
Closed -$89K 10248
2022
Q3
$89K Buy
40,800
+4,500
+12% +$15.5K ﹤0.01% 8712
2022
Q2
$127K Sell
36,300
-33,800
-48% -$126K ﹤0.01% 8512
2022
Q1
$353K Sell
70,100
-47,300
-40% -$240K ﹤0.01% 8122
2021
Q4
$736K Sell
117,400
-148,700
-56% -$1.02M ﹤0.01% 6538
2021
Q3
$2.12M Sell
266,100
-180,400
-40% -$1.48M ﹤0.01% 4368
2021
Q2
$3.34M Buy
446,500
+237,300
+113% +$1.66M ﹤0.01% 3381
2021
Q1
$1.27M Buy
209,200
+100,800
+93% +$775K ﹤0.01% 4989
2020
Q4
$619K Sell
108,400
-93,200
-46% -$593K ﹤0.01% 5427
2020
Q3
$1.34M Buy
+201,600
New +$1.8M ﹤0.01% 3620

Other funds holding VXRT

Jane Street's VXRT Position: Q2 2025 in Review

Jane Street sold out of Vaxart (VXRT) in Q2 2025, closing a stake of 30,516 shares — an estimated $12.4K sold.

Jane Street first reported a position in VXRT in Q1 2014 and held it in 20 quarters. The position peaked at $1.91M in Q4 2020. 98 funds tracked by Wall St. Rank hold VXRT as of Q2 2025.

  • Jane Street reported no remaining Vaxart position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 30,516 Vaxart shares in Q2 2025, an estimated $12.4K.
  • Jane Street first reported a position in Vaxart in Q1 2014 and held it in 20 quarters.
  • Jane Street's Vaxart position peaked at $1.91M in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Vaxart as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.